Chemotherapy-Free Combination of Blinatumomab and Ponatinib in Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Updates from a Phase II Trial

被引：4

作者：

Haddad, Fadi G. ^{[1
]}

Jabbour, Elias ^{[2
]}

Short, Nicholas J. ^{[1
]}

Jain, Nitin ^{[1
]}

Huang, Xuelin ^{[3
]}

Montalban-Bravo, Guillermo ^{[1
]}

Kadia, Tapan M. ^{[1
]}

Daver, Naval ^{[1
]}

Nasnas, Cedric ^{[1
]}

Mayor, Ejiroghene ^{[4
]}

Nasnas, Patrice Eric ^{[4
]}

Deen, Wuliamatu ^{[2
]}

Zoghbi, Marianne ^{[1
]}

Thankachan, Jennifer ^{[4
]}

Loiselle, Christopher ^{[2
]}

Garris, Rebecca ^{[1
]}

Ravandi, Farhad ^{[2
]}

Kantarjian, Hagop M. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[3] Univ Texas MD Anderson Canc Ctr, Biostat, Houston, TX USA

[4] Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-188064

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[21] Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia can be Treated with Chemotherapy-Free Regimens without Transplant
Haddad, Fadi G.
Kantarjian, Hagop
Senapati, Jayastu
Jain, Nitin
Short, Nicholas J.
Jabbour, Elias
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S79 - S82
[22] Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
K-H Lee
J-H Lee
S-J Choi
J-H Lee
M Seol
Y-S Lee
W-K Kim
J-S Lee
E-J Seo
S Jang
C-J Park
H-S Chi
Leukemia, 2005, 19 : 1509 - 1516
[23] Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
Lee, KH
Lee, JH
Choi, SJ
Lee, JH
Seol, M
Lee, YS
Kim, WK
Lee, JS
Seo, EJ
Jang, S
Park, CJ
Chi, HS
LEUKEMIA, 2005, 19 (09) : 1509 - 1516
[24] Monitoring Ponatinib in a Child with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Tanimura, Kazuki
Yamasaki, Kai
Okuhiro, Yuki
Hira, Kota
Nitani, Chika
Okada, Keiko
Fujisaki, Hiroyuki
Matsumoto, Kana
Hara, Junichi
CASE REPORTS IN ONCOLOGY, 2021, 14 (01): : 24 - 28
[25] Combination of Olverembatinib and VP Regimen for Newly Diagnosed Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Tan, Xu
Chen, Guo
Ma, Yingying
Wang, Maihong
Wen, Qin
Liu, Hong
Zhang, Xi
Zhang, Cheng
BLOOD, 2024, 144 : 1449 - 1449
[26] Subgroup analysis from a phase II trial of ponatinib and blinatumomab in relapsed/refractory (R/R) Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia in lymphoid blast phase
Zoghbi, Marianne
Jabbour, Elias
Haddad, Fadi
Short, Nicholas James
Nasnas, Cedric Christophe
Macaron, Walid
Nasr, Lewis Fady
Jain, Nitin
Montalban-Bravo, Guillermo
Kadia, Tapan M.
Daver, Naval Guastad
Chien, Kelly Sharon
Valero, Yesid Alvarado
Issa, Ghayas C.
Mayor, Ejiroghene
Deen, Wuliamatu
Thankachan, Jennifer
Garris, Rebecca
Ravandi, Farhad
Kantarjian, Hagop M.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[27] The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or Philadelphia chromosome-like acute lymphoblastic leukemia
Wu, Xiaoxia
Lu, Shenqi
Zhang, Xinhui
Yang, Zhen
Sun, Aining
Wu, Depei
Zhou, Huifen
Miao, Miao
CANCER MEDICINE, 2024, 13 (17):
[28] Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib in combination with chemotherapy
Ohno R.
Current Hematologic Malignancy Reports, 2006, 1 (3) : 180 - 187
[29] Ponatinib and Chemotherapy in Adults with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Final Results of Ponalfil Clinical Trial
Ribera, Josep-Maria
Garcia, Olga
Ribera, Jordi
Montesinos, Pau
Cano, Isabel
Martinez, Pilar
Esteve, Jordi
Esteban, Daniel
Garcia-Fortes, Maria
Alonso, Natalia
Gonzalez-Campos, Jose
Bermudez, Arancha
Torrent, Anna
Genesca, Eulalia
Mercadal, Santiago
Martinez-Lopez, Joaquin
Garcia-Sanz, Ramon
BLOOD, 2021, 138
[30] PONATINIB FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA AND PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Narayanan, V.
Pollyea, D. A.
Gutman, J. A.
Jimeno, A.
DRUGS OF TODAY, 2013, 49 (04) : 261 - 269

← 1 2 3 4 5 →